SCHEMBL7859663

SCHEMBL7859663

CN1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.69
▸ POLB P06746 3/20 0.69
▸ MAPT P10636 3/20 0.69
▸ LMNA P02545 1/20 0.69
▸ RAB9A P51151 1/20 0.69
▸ MAP3K5 Q99683 4/20 0.68
▸ INSR P06213 1/20 0.58
▸ IGF1R P08069 1/20 0.58
▸ GSK3A P49840 2/20 0.56
▸ GSK3B P49841 2/20 0.56
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ MCL1 Q07820 2/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.55
▸ EIF4E P06730 1/20 0.55
▸ EIF4G1 Q04637 1/20 0.55
▸ THRB P10828 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ SIRT2 Q8IXJ6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3901622 0.88 MAPT (0.63) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL3903530 0.88 MAPT (0.63) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL7858419 0.87 POLB (0.78) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL3897031 0.87 POLB (0.78) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL3897032 0.87 POLB (0.78) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL3907019 0.87 POLB (0.61) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL3907023 0.87 POLB (0.61) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL7852520 0.85 MAPT (0.75) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL20714251 0.84 ALDH1A1 (0.80) ALDH1A1POLBMAPTLMNARAB9A
SCHEMBL3890816 0.83 MAP3K5 (0.67) ALDH1A1POLBMAPTLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 ALDH1A1 4227/4885POLB 3712/4885MAPT 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback